Vaccination

Mixed results for Moderna mRNA flu vaccine trial

US biotech company Moderna said Thursday it had mixed results from a large-scale trial of its mRNA flu shot, based on the same technology used in its successful Covid-19 vaccine.

Medical research

Unraveling long COVID's causes and impacts

Most of the time, viruses leave our bodies as quickly as they arrived. After we suffer a week or two of fever, muscle aches, and other indignities, a surge of antibodies sends the miniature invader on its way. Case closed.

Diseases, Conditions, Syndromes

A possible vaccine against the bacteria that cause UTIs

A team of researchers at Duke University has developed a vaccine against uropathogenic E. coli (UPEC), the type of bacteria that cause urinary tract infections (UTIs) in humans. In their paper published in the journal Science ...

page 4 from 40